Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
04-25 | H.C. Wainwright Adjusts Price Target on Evotec to $11 From $14, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+5.54% | 12.82B | |
+12.07% | 9.62B | |
+7.22% | 5.64B | |
+0.05% | 5.56B | |
+6.07% | 5.23B | |
+18.19% | 4.63B | |
+17.74% | 4.53B | |
+2.73% | 4.07B | |
+5.29% | 3.94B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- HC Wainwright Adjusts Price Target on Evotec to $14 From $12, Maintains Buy Rating